+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Product, By Workflow, By Application, By End-use, By Region, and Segment Forecasts, 2021-2028

  • PDF Icon

    Report

  • 150 Pages
  • October 2021
  • Region: Global
  • Grand View Research
  • ID: 5457620
The global induced pluripotent stem cells production market size is estimated to reach USD 1.76 billion by 2028, registering a CAGR of 8.0% over the forecast period. The market is driven by technological advancements in induced pluripotent cell manufacturing, rising awareness about the therapeutic potency of such cells, and extensive research on the development of regenerative medicine using induced pluripotent cells. The ability of iPS cells to differentiate with maximum diversity has been one of the key drivers propelling its usage in gene and cell therapy applications.





The high therapeutic potential of induced pluripotent stem cells (iPSCs) has expanded its applications in the past few years making significant contributions to the market revenue. For instance, extensive research activities are being carried out on iPSC-derived exosomes, organoid-generation for drug testing, and iPSC-based vaccines. iPS cells have paved the way for the commercialization of innovative cell-based therapies in regenerative medicine owing to their ability to propagate indefinitely. In addition, iPS cells have extended their applications in regenerative medicines and therapies as they effectively avoid the ethical limitations of human embryonic stem cells and lower the risks of immune rejection, contamination, & infection.

Degenerative eye disorders are the most common targeted disorders in induced pluripotent cell-based clinical trials, along with cardiac syndromes, such as myocardial ischemia and heart failure, followed by spinal cord injury and neuropathies - Parkinson’s disease, and thrombocytopenia from aplastic anemia. Moreover, the rising popularity of automated platforms for iPS cells production is further contributing to the industry growth. The automated production platform offers an ideal chance of reliable reproducibility of cells in addition to cost reduction and increases throughput.

Acknowledging the profitable opportunities posed by the market, key players in the induced pluripotent stem cells generation industry are focusing on mergers & acquisitions to strengthen their presence. In March 2021, Axol Biosciences signed a merger agreement with Censo Biotechnology. This entity is set to become one of the leading providers of products and services in the iPSC-based immune cell, neuroscience, and cardiac modeling for the drug discovery and screening market.

Induced Pluripotent Stem Cells Production Market Report Highlights

  • Widespread potential applications of iPS cells in drug development and discovery has resulted in the segment’s dominance in 2020.
  • On the other hand, regenerative medicine is expected to be the fastest-growing application segment over the forecast period due to the high usage of iPSCs in treating a number of injuries and degenerative diseases.
  • Automated platforms for iPSCs production have gained immense demand owing to the rising requirement for reproducible large-scale stem cell and differentiated progeny production, with minimum variation.
  • Research and academic institutes are projected to register the fastest CAGR from 2021 to 2028 due to a rise in the number of collaborations between researchers.
  • These collaborations are largely targeted towards finding out the potential application of iPSCs in stem cell biology, translational research, clinical investigation of diseases.
  • Favorable government initiatives, high R&D expenditure, availability of advanced research facilities & skilled professionals, and active policies pertaining to cell therapies have contributed to the dominance of the North American regional market in 2020.
  • The key players are engaged in exploring iPSC therapy to its highest potential across different emerging applications, contributing to the market growth.
  • In February 2021, Evotec entered into a partnership with the Medical Center Hamburg-Eppendorf. The partnership aims to develop iPSC- based cell therapy for the treatment of heart failure.
  • Under this partnership, Evotec and UKE will leverage their mutual strength for the development of iPSC- based therapy approach with the help of Engineered Heart Tissue for curing heart failure.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Induced Pluripotent Stem Cells Production Market

What is the estimated value of the Global Induced Pluripotent Stem Cells Production Market?

The Global Induced Pluripotent Stem Cells Production Market was estimated to be valued at $1023.41 million in 2021.

What is the growth rate of the Global Induced Pluripotent Stem Cells Production Market?

The growth rate of the Global Induced Pluripotent Stem Cells Production Market is 8.1%, with an estimated value of $1760 million by 2028.

What is the forecasted size of the Global Induced Pluripotent Stem Cells Production Market?

The Global Induced Pluripotent Stem Cells Production Market is estimated to be worth $1760 million by 2028.

Who are the key companies in the Global Induced Pluripotent Stem Cells Production Market?

Key companies in the Global Induced Pluripotent Stem Cells Production Market include LONZA, AXOL BIOSCIENCES LTD., EVOTEC, HITACHI LTD., REPROCELL INC., FATE THERAPEUTICS., THERMO FISHER SCIENTIFIC, INC., MERCK KGAA (MILLIPORESIGMA) and APPLIED STEMCELL INC..

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Internal database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.7.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.8 Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Competition Milieu
2.2 Segment Outlook
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increase in demand for iPSC over embryonic stem cells (ESCs)
3.2.1.2 Rise in the integration of automation in iPSC production
3.2.1.3 Expanding exploitation of iPSC in research
3.2.2 Market Restraint Analysis
3.2.2.1 Lack of standardized & regulated delivery of stem cell therapy
3.2.2.2 Scalable manufacturing of iPSC
3.2.3 Market Opportunity Analysis
3.2.3.1 Robust pipeline for iPSC
3.2.3.1 Use of iPSC in regenerative medicine
3.3 Penetration & Growth Prospect Mapping for Applications, 2020
3.4 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.5 Industry Analysis – Porter’s
3.6 COVID-19 Impact Analysis
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & Acquisitions
3.7.2 Technological Collaborations
3.7.3 Licensing & Partnership
3.7.4 Strategic Divestments
3.8 Public Companies
3.8.1 Competitive Dashboard Analysis
3.8.2 Market Differentiators
3.9 Private Companies
3.9.1 List Of Emerging Players
3.9.2 Funding Outlook
Chapter 4 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Process Business Analysis
4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Process Movement Analysis
4.2 Manual iPSC Production Process
4.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Manual iPSC Production Process, 2017 - 2028 (USD Million)
4.3 Automated iPSC Production Process
4.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Automated iPSC Production Process, 2017 - 2028 (USD Million)
Chapter 5 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Workflow Business Analysis
5.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Workflow Movement Analysis
5.2 Reprogramming
5.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Reprogramming, 2017 - 2028 (USD Million)
5.3 Cell Culture
5.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Cell Culture, 2017 - 2028 (USD Million)
5.4 Cell Characterization/Analysis
5.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Cell Characterization/Analysis, 2017 - 2028 (USD Million)
5.5 Engineering
5.5.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Engineering, 2017 - 2028 (USD Million)
5.6 Other
5.6.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Other Workflows, 2017 - 2028 (USD Million)
Chapter 6 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Product Business Analysis
6.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Product Movement Analysis
6.2 Instruments/Devices
6.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Instruments/Devices, 2017 - 2028 (USD Million)
6.3 Automated Platforms
6.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Automated Platforms, 2017 - 2028 (USD Million)
6.4 Consumables & Kits
6.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Consumables & Kits, 2017 - 2028 (USD Million)
6.4.2 Media
6.4.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Consumables & Kits Market Estimates And Forecast For Media, 2017 - 2028 (USD Million)
6.4.3 Kits
6.4.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Consumables & Kits Market Estimates And Forecast For Kits, 2017 - 2028 (USD Million)
6.4.4 Others
6.4.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Consumables & Kits Market Estimates And Forecast For Others, 2017 - 2028 (USD Million)
6.5 Services
6.5.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Services, 2017 - 2028 (USD Million)
Chapter 7 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Application Business Analysis
7.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Application Movement Analysis
7.2 Drug Development And Discovery
7.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Drug Development And Discovery, 2017 - 2028 (USD Million)
7.3 Regenerative Medicine
7.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Regenerative Medicine, 2017 - 2028 (USD Million)
7.4 Toxicology Studies
7.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Toxicology Studies, 2017 - 2028 (USD Million)
7.5 Others
7.5.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Other Applications, 2017 - 2028 (USD Million)
Chapter 8 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: End-Use Business Analysis
8.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: End-use Movement Analysis
8.2 Research & Academic Institutes
8.2.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Research & Academic Institutes, 2017 - 2028 (USD Million)
8.3 Biotechnology & Pharmaceutical Companies
8.3.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Biotechnology & Pharmaceutical Companies, 2017 - 2028 (USD Million)
8.4 Hospitals & Clinics
8.4.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast For Hospitals & Clinics, 2017 - 2028 (USD Million)
Chapter 9 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Regional Business Analysis
9.1 Induced Pluripotent Stem Cell (iPSC) Production/Generation Market: Regional Movement Analysis
9.2 North America
9.2.1 North America Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.2.2.2 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.2.2.3 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.2.2.4 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.2.2.5 U.S. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.2.3.2 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.2.3.3 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.2.3.4 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.2.3.5 Canada Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3 Europe
9.3.1 Europe Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.3.2 Germany
9.3.2.1 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.2.2 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.2.3 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.2.4 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.2.5 Germany Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.3.2 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.3.3 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.3.4 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.3.5 U.K. Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3.4 France
9.3.4.1 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.4.2 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.4.3 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.4.4 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.4.5 France Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3.5 Spain
9.3.5.1 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.5.2 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.5.3 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.5.4 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.5.5 Spain Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.3.6 Italy
9.3.6.1 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.3.6.2 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.3.6.3 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.3.6.4 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.3.6.5 Italy Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.4.2.2 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.2.3 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.4.2.4 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.4.2.5 Japan Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.4.3 China
9.4.3.1 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.4.3.2 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.3.3 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.4.3.4 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.4.3.5 China Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.4.4 India
9.4.4.1 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.4.4.2 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.4.4.3 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.4.4.4 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.4.4.5 India Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.5.2.2 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.5.2.3 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.5.2.4 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.5.2.5 Brazil Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.5.3.2 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.5.3.3 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.5.3.4 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.5.3.5 Mexico Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.6 Middle East & Africa (MEA)
9.6.1 Middle East & Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.6.2.2 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.6.2.3 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.6.2.4 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.6.2.5 South Africa Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Process, 2017 - 2028 (USD Million)
9.6.3.2 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Workflow, 2017 - 2028 (USD Million)
9.6.3.3 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Product, 2017 - 2028 (USD Million)
9.6.3.4 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By Application, 2017 - 2028 (USD Million)
9.6.3.5 Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Production/Generation Market Estimates And Forecast, By End-use, 2017 - 2028 (USD Million)
Chapter 10 Company Profile
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 LONZA
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 AXOL BIOSCIENCES LTD.
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 EVOTEC
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.4 Strategic Initiatives
10.3.4 HITACHI LTD.
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 REPROCELL INC.
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 FATE THERAPEUTICS.
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 THERMO FISHER SCIENTIFIC, INC.
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 MERCK KGAA (MILLIPORESIGMA)
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 STEMCELLFACTORY III
10.3.9.1 Company Overview
10.3.9.2 Osiris Therapeutics Inc.
10.3.9.3 Financial Performance
10.3.9.4 Product Benchmarking
10.3.9.5 Strategic Initiatives
10.3.10 APPLIED STEMCELL INC.
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.5 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 3 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 4 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 5 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 6 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 7 North America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 8 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 9 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 10 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 11 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 12 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 13 U.S. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 14 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 15 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 16 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 17 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 18 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 19 Canada induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 20 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 21 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 22 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 23 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 24 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 25 Europe induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 26 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 27 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 28 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 29 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 30 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 31 Germany induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 32 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 33 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 34 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 35 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 36 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 37 U.K. induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 38 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 39 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 40 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 41 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 42 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 43 France induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 44 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 45 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 46 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 47 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 48 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 49 Italy induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 50 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 51 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 52 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 53 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 54 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 55 Spain induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 56 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 57 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 58 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 59 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 60 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 61 Asia Pacific induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 62 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 63 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 64 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 65 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 66 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 67 Japan induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 68 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 69 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 70 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 71 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 72 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 73 China induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 74 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 75 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 76 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 77 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 78 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 79 India induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 80 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 81 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 82 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 83 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 84 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 85 Latin America induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 86 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 87 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 88 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 89 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 90 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 91 Brazil induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 92 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 93 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 94 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 95 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 96 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 97 Mexico induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 98 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 99 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 100 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 101 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 102 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 103 Middle East & Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 104 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 105 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 106 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 107 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 108 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 109 South Africa induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
Table 110 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by process, 2017-2028 (USD Million)
Table 111 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by workflow, 2017-2028 (USD Million)
Table 112 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by product, 2017-2028 (USD Million)
Table 113 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by consumables & kits, 2017-2028 (USD Million)
Table 114 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by application, 2017-2028 (USD Million)
Table 115 Saudi Arabia induced pluripotent stem cell (iPSC) production/generation market estimates and forecast by end-use, 2017-2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market trends & outlook
Fig. 9 Induced pluripotent stem cell (iPSC) production/generation market driver impact
Fig. 10 Induced pluripotent stem cell (iPSC) production/generation market restraint impact
Fig. 11 Induced pluripotent stem cell (iPSC) production/generation market restraint impact
Fig. 12 Penetration & growth prospect mapping for products, 2020
Fig. 13 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Induced pluripotent stem cell (iPSC) production/generation market: Process outlook and key takeaways
Fig. 16 Induced pluripotent stem cell (iPSC) production/generation market: Process movement analysis
Fig. 17 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for manual iPSC production process, 2017-2028 (USD Million)
Fig. 18 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for automated iPSC production process, 2017-2028 (USD Million)
Fig. 19 Induced pluripotent stem cell (iPSC) production/generation market: Workflow outlook and key takeaways
Fig. 20 Induced pluripotent stem cell (iPSC) production/generation market: Workflow movement analysis
Fig. 21 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for reprogramming, 2017-2028 (USD Million)
Fig. 22 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for cell culture, 2017-2028 (USD Million)
Fig. 23 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for cell characterization/analysis, 2017-2028 (USD Million)
Fig. 24 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for engineering, 2017-2028 (USD Million)
Fig. 25 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for other workflows, 2017-2028 (USD Million)
Fig. 26 Induced pluripotent stem cell (iPSC) production/generation market: Product outlook and key takeaways
Fig. 27 Induced pluripotent stem cell (iPSC) production/generation market: Product movement analysis
Fig. 28 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for Instruments/devices, 2017-2028 (USD Million)
Fig. 29 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for media, 2017-2028 (USD Million)
Fig. 30 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for kits, 2017-2028 (USD Million)
Fig. 31 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for other consumables, 2017-2028 (USD Million)
Fig. 32 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for automated platforms, 2017-2028 (USD Million)
Fig. 33 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for consumables & kits, 2017-2028 (USD Million)
Fig. 34 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for services, 2017-2028 (USD Million)
Fig. 35 Induced pluripotent stem cell (iPSC) production/generation market: Application outlook and key takeaways
Fig. 36 Induced pluripotent stem cell (iPSC) production/generation market: Application movement analysis
Fig. 37 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for drug development and discovery, 2017-2028 (USD Million)
Fig. 38 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for regenerative medicine, 2017-2028 (USD Million)
Fig. 39 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for toxicology studies, 2017-2028 (USD Million)
Fig. 40 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for others, 2017-2028 (USD Million)
Fig. 41 Induced pluripotent stem cell (iPSC) production/generation market: End-use outlook and key takeaways
Fig. 42 Induced pluripotent stem cell (iPSC) production/generation market: End-use movement analysis
Fig. 43 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for research and academic institutes, 2017-2028 (USD Million)
Fig. 44 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for biotechnology & pharmaceutical companies, 2017-2028 (USD Million)
Fig. 45 Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast for hospitals & clinics, 2017-2028 (USD Million)
Fig. 46 Induced pluripotent stem cell (iPSC) production/generation market: Regional outlook and key takeaways
Fig. 47 Induced pluripotent stem cell (iPSC) production/generation market: Regional movement analysis
Fig. 48 North America Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 49 U.S. Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 50 Canada Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 51 Europe Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 52 U.K. Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 53 Germany Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 54 France Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 55 Italy Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 56 Spain Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 57 Asia Pacific Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 58 China Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 59 Japan Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 60 India Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 61 Latin America Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 62 Brazil Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 63 Mexico Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 64 Middle East & Africa Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 65 South Africa Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 66 Saudi Arabia Induced pluripotent stem cell (iPSC) production/generation market estimates and forecast, 2017-2028 (USD Million)
Fig. 67 Strategy framework
Fig. 68 Market participation categorization

Companies Mentioned

  • LONZA
  • AXOL BIOSCIENCES LTD.
  • EVOTEC
  • HITACHI LTD.
  • REPROCELL INC.
  • FATE THERAPEUTICS.
  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA (MILLIPORESIGMA)
  • STEMCELLFACTORY III
  • APPLIED STEMCELL INC.

Methodology

Loading
LOADING...